Sagimet Biosciences Inc. - Balanse (Quarterly)

Sagimet Biosciences Inc.
DE ˙ DB ˙ US7867001049
Balanse (Quarterly)

Sagimet Biosciences Inc. Balansen viser selskapets kontosaldoer på bestemte tidspunkter. Balansen omfatter eiendeler, omløpsmidler, anleggsmidler, varige driftsmidler, varelager, immaterielle eiendeler, gjeld, kortsiktig gjeld, gjeld, leieforpliktelser, ordinære aksjer, opptjent egenkapital, egne aksjer og egenkapital.

Alle tall er ganger 1,000,000.00 med unntak av enheter per aksje.

2020
12-31
2021
12-31
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Penger 69 57 0 12 19 102 75 177 96 77 76 65 42
Endring (%) −17,42 −99,72 7 708,86 50,01 450,26 −26,22 135,27 −45,72 −19,74 −1,52 −14,67 −34,60
Eiendeler Omløp 69 59 33 27 21 103 97 194 167 157 153 146 127
Endring (%) −14,66 −44,10 −17,52 −21,05 381,48 −6,00 101,24 −14,26 −5,73 −2,81 −4,39 −12,92
Eiendeler 69 59 33 27 21 103 97 195 189 175 160 146 137
Endring (%) −14,40 −44,05 −17,49 −21,12 378,77 −6,03 101,13 −2,83 −7,54 −8,31 −8,79 −6,00
Forpliktelser 2 3 5 5 5 5 6 5 6 4 4 7 7
Endring (%) 34,89 101,24 −0,65 −0,73 −4,48 11,96 −20,23 27,01 −28,56 8,85 61,20 0,93
Egenkapital 67 56 28 22 16 98 91 190 183 171 156 139 130
Endring (%) −15,85 −50,91 −20,76 −26,07 503,76 −6,96 108,66 −3,54 −6,88 −8,72 −10,79 −6,35
Gjeld og aksjer 69 59 33 27 21 103 97 195 189 175 160 146 137
Endring (%) −14,40 −44,05 −17,49 −21,12 378,77 −6,03 101,13 −2,83 −7,54 −8,31 −8,79 −6,00

Source: Capital IQ

Other Listings
US:SGMT USD 7,04
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista